Public elementary and secondary schools; student diabetes medical care and management. Establishes several provisions relating to student diabetes medical care and management in public elementary and secondary schools in the Commonwealth, including requiring divisionwide plans for the care of students who are diagnosed with diabetes in each school division, effective beginning with the 2028–2029 school year. This bill incorporates HB 624 and is identical to SB 122.
State Board of Health regulations; standards for levels of neonatal care. Directs the State Board of Health to establish standards for designation of care in neonatal services consistent with, but not necessarily identical to, standards published by the American Academy of Pediatrics. The bill directs the Board of Health to promulgate regulations to implement the provisions of the bill by July 1, 2027, and prohibits enforcement of such regulations until July 1, 2029. This bill is identical to HB 456.
Health insurance; prohibited restrictions on in-network referrals. Prohibits a health insurance carrier from prohibiting an in-network provider, as defined in the bill, from referring any enrollee or specimen to any in-network clinical laboratory or in-network pathology service provider under the terms of such insurance unless such referral would constitute a violation of certain laws. This bill is identical to HB 424.
Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care and is identical to HB 712.
Public elementary and secondary schools; student diabetes medical care and management. Establishes several provisions relating to student diabetes medical care and management in public elementary and secondary schools in the Commonwealth, including requiring divisionwide plans for the care of students who are diagnosed with diabetes in each school division, effective beginning with the 2028–2029 school year. This bill is identical to HB 1301.
Board of Pharmacy; regulation of psilocybin. Directs the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon approval by the U.S. Food and Drug Administration of a formulation of psilocybin designed to be administered by a health care professional in a health care setting. This bill is identical to HB 1347.
Local and regional suicide fatality review teams; penalty. Permits localities or combinations of localities to establish a local or regional suicide fatality review team. The bill provides exemptions from the Virginia Freedom of Information Act for information and records obtained or created regarding a review of a fatality by such team.
Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care and is identical to SB 641.
Department of Behavioral Health and Developmental Services; individuals receiving services; right to send and receive mail. Allows state facilities operated by the Department of Behavioral Health and Developmental Services to process sealed letter mail for electronic delivery. This bill is identical to SB 580.
Department of Medical Assistance Services; expedited review process for Medicaid service authorization requests; report. Directs the Department of Medical Assistance Services to (i) implement expedited review of Medicaid service authorization requests consistent with applicable federal law and (ii) annually transmit the prior authorization report required by the Centers for Medicare and Medicaid Services to the Chairs of the House Committees on Appropriations and Health and Human Services and the Senate Committees on Finance and Appropriations and Education and Health.
